The toxins associated with infectious diseases are potential targets for inhibitors which have the potential for prophylactic or therapeutic use. Many antibodies have been generated for this purpose, and the objective of this study was to develop a simple mathematical model that may be used to evaluate the potential protective effect of antibodies. This model was used to evaluate the contributions of antibody affinity and concentration to reducing antibody-receptor complex formation and internalization. The model also enables prediction of the antibody kinetic constants and concentration required to provide a specified degree of protection. We hope that this model, once validated experimentally, will be a useful tool for in vitro selection ...
Previously, a model has been developed and used to quantitate the antibody characteristics which inf...
Antibodies binding to the surface of virions can lead to virus neutralisation. Different theories ha...
For mAbs to be viable therapeutics, they must be formulated to have low viscosity, be chemically sta...
A mathematical model decribing the interaction of toxin, antibody and cell receptors when cell is pl...
Infectious diseases such as SARS-CoV-2 pose a considerable threat to public health. Constructing a r...
A mathematical model has been developed to optimize tumor targeting with labeled antibodies. The mod...
Therapeutic antibodies are one of the major classes of med-ical countermeasures that can provide pro...
Quantitative modeling is increasingly utilized in the drug discovery and development process, from t...
Measurable levels of immunoglobulin G antibodies develop after infections with and vaccinations agai...
Patient antibody reacting against foreign antigen is a key part of both primary and secondary immune...
For many vaccines the amount of antibodies induced has a positive correlation with the likelihood of...
In the development of new vaccines, understanding the level of vaccine-induced antibody that is suff...
SummaryEfforts to prevent human immunodeficiency virus type 1 (HIV-1) infection would benefit from u...
The potential of broadly neutralizing antibodies targeting the HIV-1 envelope trimer to prevent HIV-...
A: Step function with antibody levels higher than the 1 mcg/mL threshold produced sterilizing immuni...
Previously, a model has been developed and used to quantitate the antibody characteristics which inf...
Antibodies binding to the surface of virions can lead to virus neutralisation. Different theories ha...
For mAbs to be viable therapeutics, they must be formulated to have low viscosity, be chemically sta...
A mathematical model decribing the interaction of toxin, antibody and cell receptors when cell is pl...
Infectious diseases such as SARS-CoV-2 pose a considerable threat to public health. Constructing a r...
A mathematical model has been developed to optimize tumor targeting with labeled antibodies. The mod...
Therapeutic antibodies are one of the major classes of med-ical countermeasures that can provide pro...
Quantitative modeling is increasingly utilized in the drug discovery and development process, from t...
Measurable levels of immunoglobulin G antibodies develop after infections with and vaccinations agai...
Patient antibody reacting against foreign antigen is a key part of both primary and secondary immune...
For many vaccines the amount of antibodies induced has a positive correlation with the likelihood of...
In the development of new vaccines, understanding the level of vaccine-induced antibody that is suff...
SummaryEfforts to prevent human immunodeficiency virus type 1 (HIV-1) infection would benefit from u...
The potential of broadly neutralizing antibodies targeting the HIV-1 envelope trimer to prevent HIV-...
A: Step function with antibody levels higher than the 1 mcg/mL threshold produced sterilizing immuni...
Previously, a model has been developed and used to quantitate the antibody characteristics which inf...
Antibodies binding to the surface of virions can lead to virus neutralisation. Different theories ha...
For mAbs to be viable therapeutics, they must be formulated to have low viscosity, be chemically sta...